Anzeige
❌
Mehr »
Samstag, 10.10.2026 - Börsentäglich über 12.000 News
Private-Equity-Performance ohne den Fonds: Nehmen Sie einfach das Börsenkürzel
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
307 Leser
Artikel bewerten:
(1)

FutureRx Launches Paradigm-Shifting Healthcare Platform for Health Plans and PBMs

TAMPA, FL / ACCESSWIRE / February 21, 2023 / FutureRx (FRx) announced today the launch of its first-of-a-kind healthcare platform for health plans and pharmacy benefits managers (PBMs) that combines modular technology solutions and, if needed, seamless access to pre-vetted fully integrated service providers on a single platform. FRx is a cloud-based, modular, user-configurable technology platform that was built from the ground up to meet complex and continuously evolving compliance requirements in today's Medicare and Medicaid environment. As such, it is 100% compliant with government-sponsored regulations out of the box.

Once on the platform, health plan and PBM users can select from a full range of technology modules - including Rx Prior Authorization, Appeals/Grievances, Part D Stars, Drug Management Programs (DMP) and more - that are preconfigured out of the box with workflow and letters, and fully integrated with SureScripts and CoverMyMeds, as well as fax, phone, email, and mail capabilities that eliminate costly and time-consuming implementations.

If additional support service is needed by our customers, the FRx Marketplace provides access to a comprehensive network of pre-vetted partners that deliver a full range of specialized services. These services include, but are not limited to, customer service, formulary and rebate management, prior authorization, appeals and grievance management, mobile low-cost drug alternatives, and more. FRx Marketplace service partners are fully integrated with FRx technology modules for rapid go-to-market and hassle-free service changes.

As an added benefit, FRx customers can utilize their excess capacity or specialized skill set to sell their services on the FRx Marketplace - gaining a revenue stream without needing to retrain their staff.

"The FutureRx model is a game-changer that puts control back into the hands of the health plan or PBM. By offering the flexibility to scale services up or down as needed with pre-configured connections, FRx prevents vendor lock-in and eliminates the costs and headaches involved with service provider integrations," said Anil Kottoor, founder and CEO, FutureRx. "Importantly, our customers can switch between vendors on the FRx Marketplace whenever and as often as they like without compromising their data, which remains on the FRx platform and always under the customer's control."

"Our goal with FRx and the FRx Marketplace is to let health plans and PBMs take back control of their business processes by eliminating the hassles of vetting, contracting, and managing key outsourced service relationships," said Mark Francen, chief product officer, FutureRx. "It represents the culmination of years of research by our team of highly experienced healthcare and technology innovators into the ways traditional PBM and health plan relationships fall short and the best approaches to correct those shortcomings."

Follow us on LinkedIn, Twitter, and Facebook.

About FutureRx
FutureRx (FRx) offers a first-of-its-kind healthcare platform for health plans and pharmacy benefits managers (PBMs) that combines technology and access to pre-vetted fully integrated service providers on a single platform. FRx is a cloud-based, modular, user-configurable technology solution that was built from the ground up to meet complex and continuously evolving compliance requirements in today's Medicare and Medicaid environment. The FRx Marketplace provides access to a comprehensive network of pre-vetted partners delivering a full range of specialized services including formulary and rebate management, prior authorization, appeals and grievance management, mobile low-cost drug alternatives, and more. FRx Marketplace service partners are fully integrated with FRx technology solutions for rapid go-to-market and hassle-free service changes. FRx customers can also gain a new revenue stream by selling their services on the FRx Marketplace. For more information, visit https://futurerx.com/.

Media Contact:
Liz Goar, NPC Creative Services
813.333.2844
liz@npccs.com

SOURCE: FutureRx

View source version on accesswire.com:
https://www.accesswire.com/740020/FutureRx-Launches-Paradigm-Shifting-Healthcare-Platform-for-Health-Plans-and-PBMs

© 2023 ACCESS Newswire
KI-Euphorie kippt - Bei diesen 5 Aktien droht der Crash!
Drei Jahre lang kannten KI-Aktien fast nur eine Richtung: nach oben. Billionenschwere Investitionspläne von Alphabet, Amazon, Meta und Microsoft haben Halbleiter- und Infrastrukturwerte auf immer neue Höhen getrieben. Doch jetzt bekommt die Erfolgsstory gefährliche Risse.

Steigende Anleiherenditen verteuern die Finanzierung, während die gewaltigen KI-Ausgaben zunehmend nicht mehr aus den laufenden Cashflows bezahlt werden können. Gleichzeitig zeigen günstigere chinesische Modelle, dass leistungsfähige KI womöglich mit deutlich weniger Rechenleistung auskommt. Damit wächst die Gefahr, dass heute für Milliarden errichtete Kapazitäten morgen nicht die erhofften Renditen liefern.

Für Anleger könnte das zum Problem werden. Denn treffen steigende Finanzierungskosten auf Überkapazitäten und enttäuschende Cashflows, geraten gerade hoch bewertete KI-Profiteure schnell unter Druck. Aus den größten Gewinnern der vergangenen Jahre könnten so die größten Verlierer der nächsten Korrektur werden.

In unserem aktuellen Spezialreport zeigen wir 5 Aktien, bei denen das Chance-Risiko-Verhältnis jetzt besonders gefährlich erscheint – und bei denen Anleger genauer hinschauen sollten.

Jetzt den kostenlosen Report sichern – bevor die KI-Euphorie ihren nächsten Realitätstest erlebt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.